This clinical trial is focused on studying two eye conditions: ocular hypertension and primary open-angle glaucoma. These conditions are related to increased pressure in the eye, which can lead to vision problems if not managed properly. The study will use two types of eye drops containing the active ingredient latanoprost. One type of eye drop is called Xalatan, and the other is Monoprost, which is preservative-free. The purpose of the study is to compare the effects of these two treatments on the density of goblet cells, which are cells in the eye that help keep it moist and healthy.
Participants in the study will receive either the Xalatan or Monoprost eye drops. The study will observe changes in goblet cell density over a period of time. Additionally, the study will monitor changes in eye pressure and other factors related to eye health, such as the concentration of certain substances in the tear film and the condition of the eye’s surface. The study will also assess any changes in symptoms related to dry eye.
The trial aims to provide valuable information on how these treatments affect eye health, particularly in terms of maintaining moisture and reducing pressure in the eye. This information could help improve treatment options for people with ocular hypertension and primary open-angle glaucoma.



Denmark